Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease modifying antirheumatic drugs: results from the BIOBADASER III registry
23/10/2025
Molina J et al
Rheumatology (Oxford)
https://doi.org/10.1093/rheumatology/keaf556
doi: 10.1093/rheumatology/keaf556